Synapse - David Scheinberg

Results (30)

Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

Journal Article

Şenbabaoğlu, Y.; Gejman, R. S.; Winer, A. G.; Liu, M.; Van Allen, E. M.; de Velasco, G.; Miao, D.; Ostrovnaya, I.; Drill, E.; Luna, A.; more...
Genome Biology (2016)

Fulltext@MSK | Save

The Warburg effect confers adverse outcome in chronic lymphocytic leukemia

Meeting Abstract

Gardner, J. R.; Devlin, S. M.; Knapp, K.; Bauli, F.; Patel, M.; Lamanna, N.; Frattini, M. G.; Brentjens, R.; Maslak, P.; Jurcic, J. G.; more...
Clinical Lymphoma, Myeloma and Leukemia (2014)

Fulltext@MSK | Save

Aerobic glycolysis predicts outcome in early chronic lymphocytic leukemia

Meeting Abstract

Gardner, J. R.; Devlin, S.; Knapp, K.; Bauli, F.; Lamanna, N.; Frattini, M. G.; Brentjens, R. J.; Maslak, P. G.; Jurcic, J. G.; Weiss, M.; more...
Blood (2012)

Fulltext@MSK | Save

Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)

Meeting Abstract

Krug, L. M.; Tsao, A. S.; Kass, S.; Rusch, V. W.; Travis, W. D.; Panageas, K.; Adusumili, P. S.; Kris, M. G.; Maslak, P. G.; Scheinberg, D. A.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Journal Article

Brentjens, R. J.; Riviere, I.; Park, J. H.; Davila, M. L.; Wang, X.; Stefanski, J.; Taylor, C.; Yeh, R.; Bartido, S.; Borquez-Ojeda, O.; more...
Blood (2011)

Fulltext@MSK | Save

(124)I-huA33 antibody PET of colorectal cancer

Journal Article

Carrasquillo, J. A.; Pandit-Taskar, N.; O'Donoghue, J. A.; Humm, J. L.; Zanzonico, P.; Smith-Jones, P. M.; Divgi, C. R.; Pryma, D. A.; Ruan, S.; Kemeny, N. E.; more...
Journal of Nuclear Medicine (2011)

Fulltext@MSK | Save

Sequential cytarabine and α-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia

Journal Article

Rosenblat, T. L.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Divgi, C. R.; Panageas, K. S.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Sgouros, G.; more...
Clinical Cancer Research (2010)

Fulltext@MSK | Save

Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth

Journal Article

Penack, O.; Henke, E.; Suh, D.; King, C. G.; Smith, O. M.; Na, I. K.; Holland, A. M.; Ghosh, A.; Lu, S. X.; Jenq, R. R.; more...
JNCI: Journal of the National Cancer Institute (2010)

Fulltext@MSK | Save

Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses

Journal Article

Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

High-throughput identification of inhibitors of human mitochondrial peptide deformylase

Journal Article

Antczak, C.; Shum, D.; Escobar, S.; Bassit, B.; Kim, E.; Seshan, V. E.; Wu, N.; Yang, G.; Ouerfelli, O.; Li, Y. M.; more...
Journal of Biomolecular Screening (2007)

Fulltext@MSK | Save